Evidence map›Paper›PMID 35631675›Full record

ArticlePharmaceutics2022

The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide.

Claudia Herrera-León, Francisco Ramos-Martín, Hassan El Btaouri, Viviane Antonietti, Pascal Sonnet, Laurent Martiny, Fabrizia Zevolini, Chiara Falciani, Catherine Sarazin, Nicola D'Amelio

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. CHARMM-GUIJournal of chemical theory and computation · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Claudia Herrera-LeónUnité de Génie Enzymatique et Cellulaire UMR 7025 CNRS, Université de Picardie Jules Verne, 80039 Amiens, France.ORCID 0000-0003-2804-6732
Francisco Ramos-MartínUnité de Génie Enzymatique et Cellulaire UMR 7025 CNRS, Université de Picardie Jules Verne, 80039 Amiens, France.ORCID 0000-0002-1059-491X
Hassan El BtaouriMatrice Extracellulaire et Dynamique Cellulaire UMR 7369 CNRS, Université de Reims Champagne Ardenne (URCA), 51100 Reims, France.ORCID 0000-0003-3069-4798
Viviane AntoniettiAgents Infectieux, Résistance et Chimiothérapie, AGIR UR 4294, Université de Picardie Jules Verne, UFR de Pharmacie, 80037 Amiens, France.
Pascal SonnetAgents Infectieux, Résistance et Chimiothérapie, AGIR UR 4294, Université de Picardie Jules Verne, UFR de Pharmacie, 80037 Amiens, France.ORCID 0000-0003-0118-9151
Laurent MartinyMatrice Extracellulaire et Dynamique Cellulaire UMR 7369 CNRS, Université de Reims Champagne Ardenne (URCA), 51100 Reims, France.ORCID 0000-0002-4667-2860
Fabrizia ZevoliniDepartment of Medical Biotechnology, University of Siena, 53100 Siena, Italy.
Chiara FalcianiDepartment of Medical Biotechnology, University of Siena, 53100 Siena, Italy.
Catherine SarazinUnité de Génie Enzymatique et Cellulaire UMR 7025 CNRS, Université de Picardie Jules Verne, 80039 Amiens, France.
Nicola D'AmelioUnité de Génie Enzymatique et Cellulaire UMR 7025 CNRS, Université de Picardie Jules Verne, 80039 Amiens, France.ORCID 0000-0002-4400-2222
Centre National de la Recherche Scientifique · FRAgents infectieux, résistance et chimiothérapie · FRUniversity of Siena · IT

Funding

Conseil Régional des Hauts-de-France not applicableConsejo Nacional de Ciencia y Tecnología not applicableThe European Regional Development Fund (ERDF) not applicable
6 · The paper itself

Abstract

Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.

Indexed as

anticancerantimicrobialbiomembranesmolecular dynamicsNMRpeptidessequence alignment

Identifiers

PMID35631675
PMCPMC9147034
OpenAlexW4280639615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.